Macquarie Group’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-6,489
Closed -$46K 2305
2018
Q4
$46K Buy
+6,489
New +$72.3K ﹤0.01% 1612
2016
Q1
Sell
-12,184
Closed -$1.21M 1626
2015
Q4
$1.21M Hold
12,184
﹤0.01% 1047
2015
Q3
$1.49M Buy
12,184
+564
+5% +$76.6K ﹤0.01% 1048
2015
Q2
$1.78M Buy
11,620
+2,024
+21% +$334K ﹤0.01% 1054
2015
Q1
$1.64M Buy
9,596
+187
+2% +$28.3K ﹤0.01% 1060
2014
Q4
$1.44M Buy
+9,409
New +$1.17M ﹤0.01% 1096

Other funds holding ELGX

Macquarie Group's ELGX Position: Q1 2019 in Review

Macquarie Group sold out of Endologix Inc (ELGX) in Q1 2019, closing a stake of 6,489 shares — an estimated $46K sold.

Macquarie Group first reported a position in ELGX in Q4 2014 and held it in 6 quarters. The position peaked at $1.78M in Q2 2015. 63 funds tracked by Wall St. Rank hold ELGX as of Q1 2019.

  • Macquarie Group reported no remaining Endologix Inc position as of Q1 2019 after selling out during the quarter.
  • Macquarie Group sold 6,489 Endologix Inc shares in Q1 2019, an estimated $46K.
  • Macquarie Group first reported a position in Endologix Inc in Q4 2014 and held it in 6 quarters.
  • Macquarie Group's Endologix Inc position peaked at $1.78M in Q2 2015.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2019.

Based on Macquarie Group's 13F filing for Q1 2019, filed 15 May 2019.